The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
A Multiple Testing Procedure for Clinical Trials
O'Brien, P. C., & Fleming, T. R. (1979) · Biometrics · doi:10.2307/2530245 · Cited by 3,311
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Self-citationClassification of chronic hepatitis: Diagnosis, grading and staging
Desmet, V. J., Gerber, M., Hoofnagle, J. H., Manns, M., & Scheuer, P. J. (1994) · Hepatology · doi:10.1002/hep.1840190629 · Cited by 2,593
Self-citationDiagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
Self-citationSoloway, R. D., Summerskill, W. H. J., Baggenstoss, A. H., Geall, M. G., Gitnick, G. L., Elveback, L. R., & Schoenfield, L. J. (1972) · Gastroenterology · doi:10.1016/s0016-5085(19)33223-8 · Cited by 779
Krawitt, E. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050408 · Cited by 753
Adaptive Sample Size Calculations in Group Sequential Trials
Lehmacher, W., & Wassmer, G. (1999) · Biometrics · doi:10.1111/j.0006-341x.1999.01286.x · Cited by 598
CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITIS
Murray-Lyon, I., Stern, R. B., & Williams, R. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92125-9 · Cited by 468
Manns, M., Kyriatsoulis, A., Gerken, G., Staritz, M., Meyer, K. H., & Büschenfelde, Z. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92024-1 · Cited by 424
Self-citationKirk, A. P., Jain, S., Pocock, S., Thomas, H. C., & Sherlock, S. (1980) · Gut · doi:10.1136/gut.21.1.78 · Cited by 285
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
Czaja, A. J., & Manns, M. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.053 · Cited by 280
Self-citationAutoimmune hepatitis: Clinical challenges
Manns, M. P., & Strassburg, C. P. (2001) · Gastroenterology · doi:10.1053/gast.2001.24227 · Cited by 220
Self-citationTRANSFUSION ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN AUTOLOGOUS BONE MARROW TRANSPLANTATION
Mulder, N. H., Elema, J. D., & Postmus, P. E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92261-7 · Cited by 211
Significance of HLA DR4 in type 1 autoimmune hepatitis
Czaja, A. J., Carpenter, H. A., Santrach, P. J., & Moore, S. B. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90157-8 · Cited by 206
Richardson, P. D., James, P. D., & Ryder, S. D. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80271-8 · Cited by 204
The validity and importance of subtypes in autoimmune hepatitis: a point of view.
Czaja, A. J., & Manns, M. P. (1995) · PubMed · Cited by 194
Self-citationMycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?
Hennes, E. M., Oo, Y. H., Schramm, C., Denzer, U., Buggisch, P., Wiegard, C., Kanzler, S., Schuchmann, M., Boecher, W., Galle, P. R., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02180.x · Cited by 188
Self-citationThiel, D. H. V., Wright, H. I., Carroll, P. B., Abu-Elmagd, K. M., Rodriguez-Rilo, H. L., McMichael, J., Irish, W. D., & Starzl, T. E. (1995) · PubMed · Cited by 183
Cyclosporine Therapy in Patients With Steroid Resistant Autoimmune Hepatitis
Fernandes, N. F., Redeker, A. G., Vierling, J. M., Villamil, F. G., & Fong, T. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.00807.x · Cited by 155
Clinical significance of autoantibodies to soluble liver antigen in autoimmune hepatitis
Kanzler, S., Weidemann, C., Gerken, G., Löhr, H. F., Galle, P. R., Büschenfelde, K. M. Z., & Lohse, A. W. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80342-0 · Cited by 149
Self-citationOral budesonide for treatment of autoimmune chronic active hepatitis
Danielsson, A., & Prytz, H. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00334.x · Cited by 142
Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis
Czaja, A. J., & Lindor, K. D. (2000) · Gastroenterology · doi:10.1053/gast.2000.0010000001 · Cited by 123
Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis
Fernandes, N. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00688-1 · Cited by 119
Budesonide in previously untreated autoimmune hepatitis
Wiegand, J., Schüler, A., Kanzler, S., Lohse, A. W., Beuers, U. H., Kreisel, W., Spengler, U., Koletzko, S., Jansen, P. L. M., Hochhaus, G., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01122.x · Cited by 103
Self-citation
Cited by
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
Self-citationEASL Clinical Practice Guidelines: autoimmune hepatitis
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.06.030 · Cited by 1,245
“For patients without cirrhosis, when severe steroid–related side effects are likely to exacerbate poorly controlled diabetes, osteoporosis, and psychosis, budesonide 9 mg/day plus azathioprine 1–2 mg/kg/day may be an appropriate choice [193].”
BackgroundMack, C. L., Adams, D., Assis, D. N., Kerkar, N., Manns, M. P., Mayo, M. J., Vierling, J. M., Alsawas, M., Murad, M. H., & Czaja, A. J. (2020) · Hepatology · doi:10.1002/hep.31065 · Cited by 983
“(291,292) gUIDaNCe StateMeNt • Consider screening patients with AIH for absent or near-absent TPMT activity prior to initiating treatment with AZA.”
BackgroundMethodInfluentialSelf-citationNew paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond
Beuers, U., Trauner, M., Jansen, P., & Poupon, R. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.02.023 · Cited by 537
Pathogenesis of Primary Sclerosing Cholangitis and Advances in Diagnosis and Management
Eaton, J. E., Talwalkar, J. A., Lazaridis, K. N., Gores, G. J., & Lindor, K. D. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.06.052 · Cited by 436
Metadata
- Authors
- Manns, M. P., Woynarowski, M., Kreisel, W., Lurie, Y., Rust, C., Zuckerman, E., Bahr, M. J., Günther, R., Hultcrantz, R. W., Spengler, U., Lohse, A. W., Szalay, F., Färkkilä, M., Pröls, M., & Strassburg, C. P.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 139
- Issue
- 4
- Pages
- 1198-1206
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2095262005
- Cited by
- 442
- References
- 25
- FWCI
- 22.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.